Localizing the Accessory Pathway in Ventricular Preexcitation Patients Using a Score Based Algorithm

Objectives: Clinical data was analyzed to find an efficient way to localize the accessory pathway in patients with ventricular preexcitation.

Methods: The delta wave morphologies and ablation sites of 186 patients who underwent catheter ablation were analyzed and an algorithm (“locAP”) to localize the accessory pathway was developed from the 84 data sets with a PQ interval ≤ 0.12 s and a QRS width ≥ 0.12 s. Fifty additional patients were included for a prospective validation. The locAP algorithm ranks 13 locations according to the likelihood that the accessory pathway is localized there. The algorithm is based on the locAP score which uses the standardized residuals of the available data sets.

Results: The locAP algorithm’s accuracy is 0.54 for 13 locations, with a sensitivity of 0.84, a specificity of 0.97, and a positive likelihood ratio of 24.94. If the two most likely locations are regarded, the accuracy rises to 0.79, for the three most likely locations combined the accuracy is 0.82. This new algorithm performs better than Milstein’s, Fitzpatrick’s, and Arruda’s algorithm both in the original study population as well as in a prospective study.

Conclusions: The locAP algorithm is a valid and valuable tool for clinical practice in a cardiac electrophysiology laboratory. It could be shown that use of the locAP algorithm is favorable over the localizing algorithms that are in clinical use today.

Detection of phase singularities in triangular meshes

OBJECTIVES

Phase singularities have become a key marker in animal and computer models of atrial and ventricular fibrillation. However, existing algorithms for the automatic detection of phase singularities are limited to regular, quadratic mesh grids. We present an algorithm to automatically and exactly detect phase singularities in triangular meshes.

METHODS

For each node an oriented path inscribing the node with one unit of spatial discretization is identified. At each time step the phase information is calculated for all nodes. The so-called topological charge is also computed for each node. A non-zero (+/- 2pi) charge is obtained for all nodes with a path enclosing a phase singularity. Thus all charged nodes belonging to the same phase singularity have to be clustered.

RESULTS

With the use of the developed algorithm, phase singularities can be detected in triangular meshes with an accuracy of below 0.2 mm - independent of the type of membrane kinetics used.

CONCLUSIONS

With the possibility to detect phase singularities automatically and exactly, important quantitative data on cardiac fibrillation can be gained.

Homocysteine impairs the nitric oxide synthase pathway: role of asymmetric dimethylarginine

BACKGROUND

Hyperhomocysteinemia is a putative risk factor for cardiovascular disease, which also impairs endothelium-dependent vasodilatation. A number of other risk factors for cardiovascular disease may exert their adverse vascular effects in part by elevating plasma levels of asymmetric dimethylarginine (ADMA), an endogenous inhibitor of nitric oxide synthase. Accordingly, we determined if homocysteine could increase ADMA levels.

METHODS AND RESULTS

When endothelial or nonvascular cells were exposed to DL-homocysteine or to its precursor L-methionine, ADMA concentration in the cell culture medium increased in a dose- and time-dependent fashion. This effect was associated with the reduced activity of dimethylarginine dimethylaminohydrolase (DDAH), the enzyme that degrades ADMA. Furthermore, homocysteine-induced accumulation of ADMA was associated with reduced nitric oxide synthesis by endothelial cells and segments of pig aorta. The antioxidant pyrrollidine dithiocarbamate preserved DDAH activity and reduced ADMA accumulation. Moreover, homocysteine dose-dependently reduced the activity of recombinant human DDAH in a cell free system, an effect that was due to a direct interaction between homocysteine and DDAH.

CONCLUSION

Homocysteine post-translationally inhibits DDAH enzyme activity, causing ADMA to accumulate and inhibit nitric oxide synthesis. This may explain the known effect of homocysteine to impair endothelium-mediated nitric oxide-dependent vasodilatation.